Dr. Michael Scott Sabel, MD

Dr. Sabel practices at University Hospital in Ann Arbor, Michigan.

Dr. Sabel's NPI, 1306947221, was assigned on September 25, 2006. Dr. Sabel graduated from Temple University School of Medicine in 1992. Dr. Sabel holds Michigan license 4301077719.

Dr. Sabel's primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.

Dr. Sabel's primary practice is University Hospital in Ann Arbor, Michigan. Dr. Sabel is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dmand AI also links Dr. Sabel to 1 more home health agency, named with a free account. Dr. Sabel's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sabel practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Sabel's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Sabel is licensed in Michigan.

CMS data shows 119 Medicare services from Dr. Sabel across 5 procedure codes in 2024, for 98 Medicare patients. Medicare paid $14,650 for them.

CMS counts 98 Medicare patients who saw Dr. Sabel in 2024. The largest group is 65 to 74, with 45 patients. 71% of them have cancer, and 59% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sabel's median patient age at 65, with 87% women.

In 2024, Dr. Sabel wrote 19 Medicare Part D claims. 84% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $42 in total drug cost. In 2016, CMS named 15 claims across 1 drug.

Dr. Sabel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sabel as offering telehealth. CMS counts 42 procedures of mastectomy by Dr. Sabel, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 230 papers to Dr. Sabel, published from 2003 to 2025. 2017 was the busiest year, with 21. The most frequent topics are Brain Neoplasms, Glioma and Glioblastoma. Dr. Sabel has published most often in Acta Neurochir (Wien). Dr. Sabel's most frequent co-authors are Alfred E. Chang, MD, Lesly Ann Dossett, MD and Michael Andrew Weller, MD.

Dmand AI links Dr. Sabel to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Brain Neoplasms, Glioblastoma and Astrocytoma.

CMS Open Payments shows 9 general payments to Dr. Sabel from 2 drug and device companies from 2019 to 2024. Travel and lodging make up the largest share, 66% of the total. Endomagnetics Ltd paid the most, $5,482.

Dr. Sabel graduated from Temple University School of Medicine in 1992.